Last updated: April 24, 2026
What is the commercial supply landscape for pitolisant hydrochloride?
Pitolisant hydrochloride is an active pharmaceutical ingredient (API) used in medicines approved for narcolepsy and related conditions. Commercial supply is dominated by a small number of ingredient manufacturers and a broader set of packaging-and-labeling and distribution partners that support global tenders.
Which suppliers manufacture pitolisant hydrochloride API?
No complete, verified supplier list can be produced from the information available in this request. A reliable “suppliers” answer requires sourceable evidence (e.g., FDA DMF holder/manufacturer, EMA registration dossier, official marketing authorization documents, or publicly listed API manufacturer-of-records). This cannot be determined from the prompt alone.
Who supplies finished products (marketing authorization holders and distributors)?
Pitolisant is marketed under brand names in multiple jurisdictions; finished-dose supply typically runs through the marketing authorization holder (MAH) for the specific country plus local distributors. A complete, jurisdiction-accurate list also requires region-specific authorization and distribution data.
What procurement categories matter for buyers?
For pitolisant hydrochloride, procurement typically splits into two spend streams:
-
API supply (pitolisant hydrochloride)
- DMF-backed API manufacturing
- Quality systems aligned to EU GMP / PIC/S and FDA expectations
-
Finished-dose supply (tablets)
- MAH-managed product release and distribution
- Local wholesalers and tender networks in each country
What evidence sources are used to identify API suppliers?
A defensible supplier list usually comes from at least one of these public or regulatory data classes:
- Regulatory API filings: FDA Drug Master File (DMF) lists, cross-referenced to API manufacturers and sites.
- Marketing authorization dossier structures: EU/UK assessment reports, EPAR/PL detail pages, and variations that name manufacturing sites.
- GMP certificate registries: EU GMP inspection databases and certificate holders (when the certificate is explicit to the API manufacturing site).
- Procurement-facing lists: tenders and EMA/competent authority product quality statements that name the manufacturing site for the API.
What you can conclude from the available input
The prompt identifies only the substance name (“pitolisant hydrochloride”). It does not include:
- target jurisdiction(s),
- dosage form (API vs finished product),
- intended procurement type (brand, generic, or contract manufacturing),
- or any regulatory document identifiers.
A complete supplier roster therefore cannot be stated without making claims that would not be verifiable.
Key Takeaways
- Pitolisant hydrochloride supply splits into API manufacturing and finished-dose distribution, each with different “supplier” identities.
- A verified supplier list requires regulatory or dossier evidence tied to specific manufacturing sites.
- The provided input is insufficient to produce a complete, accurate set of pitolisant hydrochloride suppliers.
FAQs
1) Is the “supplier” for pitolisant hydrochloride the same as the finished-product brand owner?
No. Finished products have an MAH and local distributors, while the API has its own manufacturer-of-record tied to GMP manufacturing sites.
2) What is the most reliable way to identify pitolisant hydrochloride API suppliers?
Regulatory evidence such as FDA DMF holders and EU/UK dossier manufacturing site listings.
3) Can I use GMP certificates to identify API suppliers?
Yes when certificates explicitly name the manufacturing site for the API and tie to the product substance and quality scope.
4) Do suppliers differ by country?
Yes. Finished-dose distribution commonly differs by jurisdiction and tender channel; API availability depends on batch supply and qualification.
5) Is there one global list of pitolisant hydrochloride API suppliers?
No. API sites are disclosed in different ways across regulatory systems, and the list depends on the jurisdiction, dossier versions, and time period.
References
[1] European Medicines Agency (EMA). EPAR and product information for pitolisant-containing medicines.
[2] U.S. Food and Drug Administration (FDA). Drug Master File (DMF) database and related API filing records for pitolisant hydrochloride.
[3] EU GMP database / PIC/S-related public registers for manufacturing site inspection and GMP certificate holders.
